23andMe Goes Public via Reverse IPO: $ME

Shares of 23andMe made their debut on the NASDAQ today after completing a reverse-IPO with the special purpose acquisition company (SPAC), VG Acquisition Corp. In recent years, the initial hype of this genetics and research company has worn off, but consumer mentions have maintained a consistent level, which shows some promise for the stock going forward.

The IPO attracted little fanfare at the open but has steadily gained throughout the day, up nearly +20%.

This is a company we've been tracking for some time, so be on the lookout for an official coverage addition report in the future.